We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.
- Authors
O'Connor, Owen A; Wright, John; Moskowitz, Craig; Muzzy, Jamie; MacGregor-Cortelli, Barbara; Stubblefield, Michael; Straus, David; Portlock, Carol; Hamlin, Paul; Choi, Elizabeth; Dumetrescu, Otila; Esseltine, Dixie; Trehu, Elizabeth; Adams, Julian; Schenkein, David; Zelenetz, Andrew D
- Abstract
To determine the antitumor activity of the novel proteasome inhibitor bortezomib in patients with indolent and mantle-cell lymphoma (MCL).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 4, p676
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.02.050